Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia

As in younger patients, allogeneic stem cell transplantation (alloHSCT) offers the best chance for durable remission in older patients (≥60 years) with acute myeloid leukemia (AML). However, defining the best treatment strategy (and in particular, whether or not to proceed to alloHSCT) for elderly p...

Descripción completa

Detalles Bibliográficos
Autores principales: Servais, Sophie, Beguin, Yves, Baron, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154332/
https://www.ncbi.nlm.nih.gov/pubmed/35438781
http://dx.doi.org/10.1093/stcltm/szac015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154332/
https://www.ncbi.nlm.nih.gov/pubmed/35438781
http://dx.doi.org/10.1093/stcltm/szac015

Ejemplares similares